Jing Liu

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Google:
"Jing Liu"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhang H, Liu J, Chen Q, et al. (2020) Ligand-installed anti-VEGF genomic nanocarriers for effective gene therapy of primary and metastatic tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society
Zhou H, Zhao Y, Xu J, et al. (2020) Recover the activity of sintered supported catalysts by nitrogen-doped carbon atomization. Nature Communications. 11: 335
Zhang S, Liu J, Zhang H, et al. (2020) Damage Adaptive Titanium Alloy by in-Situ Elastic Gradual Mechanism. Materials (Basel, Switzerland). 13
Zhang L, Zhang X, Zhang H, et al. (2020) Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing. Breast Cancer (Tokyo, Japan)
Zeng P, Liu J, Zhang C, et al. (2020) Current risk factors for HIV infection among blood donors in seven Chinese regions. Transfusion
Chen B, Zhang G, Wei G, et al. (2020) Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine-Related Cancer
Hao Y, Guo F, Huang Z, et al. (2020) 2-Methylquinazoline Derivative 23BB as a Highly Selective Histone Deacetylase 6 Inhibitor Alleviated Cisplatin-induced Acute Kidney Injury. Bioscience Reports
Liu J, Chen TW, Yang YL, et al. (2020) Removal of heavy metal ions and anionic dyes from aqueous solutions using amide-functionalized cellulose-based adsorbents. Carbohydrate Polymers. 230: 115619
Zeng J, Zhu L, Liu J, et al. (2019) Metformin Protects against Oxidative Stress Injury Induced by Ischemia/Reperfusion via Regulation of the lncRNA-H19/miR-148a-3p/Rock2 Axis. Oxidative Medicine and Cellular Longevity. 2019: 8768327
Wang L, Hu C, Wang A, et al. (2019) Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia models. Investigational New Drugs
See more...